| Product NDC: | 52125-022 |
| Proprietary Name: | OXYBUTYNIN CHLORIDE |
| Non Proprietary Name: | OXYBUTYNIN CHLORIDE |
| Active Ingredient(s): | 10 mg/1 & nbsp; OXYBUTYNIN CHLORIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52125-022 |
| Labeler Name: | REMEDYREPACK INC. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076745 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130225 |
| Package NDC: | 52125-022-02 |
| Package Description: | 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (52125-022-02) |
| NDC Code | 52125-022-02 |
| Proprietary Name | OXYBUTYNIN CHLORIDE |
| Package Description | 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (52125-022-02) |
| Product NDC | 52125-022 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | OXYBUTYNIN CHLORIDE |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20130225 |
| Marketing Category Name | ANDA |
| Labeler Name | REMEDYREPACK INC. |
| Substance Name | OXYBUTYNIN CHLORIDE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |